Diagnostic Tests Must before prescribing Antibiotics to patients: NMC guidelines for doctors

Published On 2024-06-19 13:27 GMT   |   Update On 2024-06-19 13:41 GMT

New Delhi: In its recently released National Action Plan on Antimicrobial Resistance (NAP-AMR) Module for Prescribers 2024, the National Medical Commission (NMC) has advised doctors to treat patients with antibiotics in the presence of diagnostic reports and cases of severity. "The decision to treat with antibiotics should be made by the presence of severity and laboratory report of sputum and culture examination," the Commission stated in the module, adding that the empiric antibiotic therapy must be limited to seriously ill patients.

Advertisement

Medical Dialogues had earlier reported that NMC released the Module for Medical students, Doctors (Residents. Faculty, Medical officers etc.) and allied health professionals (Nurses, Pharmacist, Technicians and other allied health professionals) and administrators, while considering the emerging threats of Antimicrobial Resistance (AMR), which is now one of the top global public health threats facing humanity.

It is estimated that bacterial AMR was directly responsible for 1.27 million global deaths in 2019 and 4.95 million deaths were associated with drug-resistant infections. AMR puts many of the gains of modern medicine at risk and threatens the effective prevention and treatment of infections caused by resistant microbes, resulting in prolonged illness and a greater risk of death. Treatment failures also lead to longer periods of infectivity and the prohibitive high cost of second-line drugs may result in failure to treat these diseases in many individuals.

Releasing the module, which was prepared by NMC Ethics Board's member Dr. Vijaya Lakshmi Nag and other experts, NMC discussed the objectives of NMC in this regard, clinical approach for prescribing Antimicrobials, Microbiological Diagnostic stewardship, interpretation of antimicrobial resistance- Principle and implications, antimicrobial policy, antimicrobial stewardship, infection control, Toolkit for prescribers and presentations.

While discussing the clinical approach for prescribing Antimicrobials, the Commission stressed on the importance of accurate and thorough examination and a proper communication between the clinicians and the laboratory.

"The communication between the clinicians and laboratory is vital. The positive culture reports must be conveyed rapidly to prescribers so that the therapeutic interventions can be made in desired time frame. The decision of starting antibiotics should be governed by the antibiograms. This will not only be a cost-effective approach of treating infections but also reduce AMR," NMC mentioned in the module.

Apart from this, the module also specified in detail the factors affecting the decision to prescribe antimicrobials. 

As per the Module, the prescription of antimicrobials should be based on the following steps:

Step 1: Making a clinical diagnosis based on accurate history taking and thorough clinical examination helps in selecting the right test for the right patient. A clinical diagnosis also helps in predicting most likely organism causing a clinical syndrome. The sample must be collected before the start of antimicrobials.

Step 2: The empiric antibiotic therapy must be limited to seriously ill patients. This choice should be based upon institutional/local antibiograms.

Step 3: Choose the appropriate antibiotic based on clinical evaluation and most likely pathogen keeping antibiogram in mind.

"Antibiotic prescribing is determined by various factors, including the socio-cultural and socio-economic factors of each country and the beliefs of patients and professionals regarding antibiotic use. The shortage of appropriate diagnostic tools, the insufficient regulatory policies of country can further cause an increase in over-the-counter antibiotics. Medical professionals have to be prepared appropriately in order to face the challenges of antimicrobial use in everyday clinical practice," the Commission added.

Further, the new guidelines also mentioned that recording cardinal symptoms of major systems like fever, cough, sputum, breathlessness, haemoptysis, chest pain may suggest an infective respiratory illness like pneumonia. It clarified that the decision to treat with antibiotics should be made by the presence of severity and laboratory report of sputum and culture examination.

"Jaundice and abdominal pain may be present in medical conditions like viral hepatitis, alcoholic hepatitis, leptospirosis, malaria, dengue etc. or in surgical conditions like choledocholithiasis or cholangitis. Prescribers should take a detailed history of any recent travel, drug abuse, blood transfusion, recent surgeries etc. to narrow down the differential diagnosis," it added.

NMC has also pointed out the importance of a Hospital antimicrobial policy, adding that such a policy "helps to minimize the morbidity and mortality due to antimicrobial-resistant infection; and helps to preserve the effectiveness of antimicrobial agents in the treatment and prevention of communicable diseases."

"The policy must define prophylaxis, empirical and definitive therapy and must incorporate specific recommendations for the treatment of different high-risk/special groups such as immunocompromised hosts; hospital-associated infections and community-associated infections," it added in the module.

Prescribers’ toolkit for combating AMR

Table : The competencies, learning objectives and the assessment methods

S. No. and Competency addressedLearning objectivesDomainTarget audienceTeaching learning methods (TLM)Assessment method
1. Background and objectives1.1 Understand the present burden of AMR 1.2 Understand the concept of this national program 1.3 Assist in implementing this programKPrescribersTheory session- 30 minWritten: MCQ, SAQ
2.Clinical approach for prescribing antimicrobials2.1 Identify common presentations of infective syndromes 2.2 Describe and understand the importance of taking thorough history, clinical examination and selection of appropriate investigations for diagnosis of infective disease soft tissue infections etc)KPrescribersExploratory and interactive theory session with case studies- 60 minWritten: MCQ -Case based discussion Clinical problem solving
3.Microbiolog -ical diagnostic stewardship3.1 Define diagnostic stewardship 3.2 Understand the difference between infection and colonization 3.3 Describe the sample collection techniques, precautions, transport and rejection criteria of common samples.K.A.SPrescribersExploratory and interactive theory session with demonstration of collection containers, videos for collection- 60 minWritten: SAQ, MCQ
4. Interpretation of antimicrobial sensitivity results4.1 Understand the importance of quality assured antimicrobial susceptibility testing (AST) 4.2 Interpret the antimicrobial susceptibility testing report. 4.3 Interpret the surrogate and cascade reporting.K, SPrescribersExploratory and interactive theory session with samples of AST reports60 minWritten: SAQ, MCQ, Case discussion, AST problem solving
5. Antimicrobial resistance: Principle and implications5.1 Define and explain the differences between antimicrobials and antibiotics 5.2 Outline the drivers for resistance 5.3 Outline the global epidemiology of key antimicrobial resistant pathogens and antimicrobial consumption 5.4 Explain the clinical and economic impact of drug resistant infections and health care acquired infectionsKPrescribersExploratory and interactive theory session40minWritten: SAQ, MCQ
6. Antimicrobial policy6.1 Describe the attributes and features of antimicrobial policy 6.2 Describe the key elements of developing hospital antimicrobial policy 6.3 Assist in developing antimicrobial policyKPrescribersExploratory and interactive theory session with examples from in house antibiotic policy- 30 minWritten: SAQ, MCQ
7. Antimicrobial stewardship in humans7.1 Define antimicrobial stewardship 7.2 Outline the goals, strategies and interventions of antimicrobial stewardship 7.3 Describe the core and supplemental interventions 7.4 Outline the pharmacokinetics and pharmacodynamics approach to antimicrobial prescription 7.5 Describe and interpret antibiogram 7.6 Understand the utility of antibiogram in formulating empirical therapyK, SPrescribersExploratory and interactive theory session with examples of in house antibiograms and their interpretation60 minWritten: SAQ, MCQ, Case based problem
8. Infection control8.1 Define standard precautions 8.1.1 Describe the elements of standard precautions 8.1.2 Describe moments and steps of hand hygiene 8.2 Define and describe transmission-based precautions 8.3 Define and describe various segregation methods of biomedical waste and their disposal as per BMW rules. 8.4 Define device associated infections 8.4.1 Define preventive care bundles for device associated infections 8.4.2 Describe care bundles for different types of device associated infectionsKPrescribersExploratory and interactive theory session15 + 15 + 15 + 15 min = 60 minWritten: SAQ, MCQ

What is Antimicrobial Resistance (AMR)?

Explaining the issue of AMR, the NMC module stated, "Antimicrobial Resistance (AMR) occurs when microorganisms change over time and become resistant to drugs, making common infections harder, increasing the risk of disease spread, severe illness and death. This is a significant threat as it undermines the effectiveness of antibiotics and antimicrobials, which are crucial for surgeries, chemotherapy and managing chronic infections. The emergence of multi-drug resistant organisms (MDROs) further complicates the issue, as these "superbugs" are resistant to many different antimicrobials, making infections very difficult to treat."

Terming AMR to be a "complex problem", the module mentioned that this issue requires a united multisectoral approach that considers factors like antibiotic overuse in humans and animals, hygiene practices, and development of new drugs. "It is an ongoing threat to modern medicine throughout the world with a negative effect on patient treatment outcome. Pathogens are developing mechanisms of resistance, making it difficult to treat common infectious diseases like pneumonia, tuberculosis and foodborne diseases," stated the module.

"Antibiotic prescribing is determined by various factors, including the socio-cultural and socio-economic factors of each country and the beliefs of patients and professionals regarding antibiotic use. The shortage of appropriate diagnostic tools, the insufficient regulatory policies of country can further cause an increase in over-the-counter antibiotics. Medical professionals have to be prepared appropriately in order to face the challenges of antimicrobial use in everyday clinical practice," it added.

Global Action Plan on AMR (GAP-AMR):

Understanding the gravity of the problem of antimicrobial resistance (AMR), the World Health Assembly (WHA) in 2015 adopted the Global Action Plan on AMR (GAP-AMR) in collaboration with the World Health Organization (WHO), Food & Agricultural Organization (FAO) & World Organization for Animal Health (WOAH).

The different issues discussed in the National Action Plan on Antimicrobial Resistance (NAP-AMR) Module for Prescribers are as follows:

Objectives of National Medical Commission (NMC):

Laying down the objectives of the NMC with respect of the Antimicrobial Resistance, the module mentioned that NMC aims to improve awareness and understanding of AMR through effective education and training.

The other objective of the Apex Medical Commission is to optimise the use of antimicrobial agents in human health. The intervention activities mentioned for achieving the objective are- Improve knowledge and skills of prescribers, dispensers & medical trainees.

Also Read: NMC Releases National Action Plan on Antimicrobial Resistance Module for Prescribers 2024, details

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News